New study aims to unlock secrets of CMV in transplant patients

NCT ID NCT05701228

Ongoing Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for adults receiving a kidney, lung, liver, or heart transplant. It will collect blood and tissue samples to learn how the body responds to CMV, a common virus that can cause serious problems after transplant. The goal is to better understand the virus and improve future care. No new treatments are being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOMEGALOVIRUS INFECTIONS SOLID ORGAN TRANSPLANTATION

Contacts and locations

Show contact details

Locations

Hopitel Pellegrin

Bordeaux, 33076, France
Hôpital Edouard Hériot

Lyon, 69003, France
Hôpital Foch

Suresnes, 92150, France
Hôpital LA PITIE SALPETRIERE

Paris, 75013, France
Hôpital Necker

Paris, 75015, France
Hôpital Paul Brousse

Villejuif, 94804, France
Hôpital Rangueil

Toulouse, 31059, France